3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
50
Breast Neoplasms
50
Carcinoma, Non-Small-Cell Lung
48
Prostatic Neoplasms
47
Squamous Cell Carcinoma of Head and Neck
37
Lung Neoplasms
30
Head and Neck Neoplasms
26
Glioma
23
Rectal Neoplasms
22
Sarcoma
20
Neoplasms
20
Brain Neoplasms
20
Oropharyngeal Neoplasms
16
Esophageal Neoplasms
15
Uterine Cervical Neoplasms
14
Neoplasm Metastasis
14
Astrocytoma
14
Esophageal Squamous Cell Carcinoma
13
Triple Negative Breast Neoplasms
12
Carcinoma, Hepatocellular
12
Pancreatic Neoplasms
11
Melanoma
11
Gliosarcoma
10
Colorectal Neoplasms
10
Stomach Neoplasms
9
Small Cell Lung Carcinoma
9
Lymphoma
9
Hodgkin Disease
9
Carcinoma, Squamous Cell
9
Urinary Bladder Neoplasms
8
Interventions
pembrolizumab
4
Nivolumab
4
fludarabine
3
aldesleukin
3
Ipilimumab
3
Cyclophosphamide
3
vedolizumab
2
enfortumab vedotin
2
darolutamide
2
cabozantinib
2
atezolizumab
2
Specimen Handling
2
Riluzole
2
Prednisone
2
Magnetic Resonance Spectroscopy
2
LDP-02
2
Infliximab
2
Immunoglobulin G
2
Fecal Microbiota Transplantation
2
Disulfides
2
CTLA-4 Antigen
2
CT-P13
2
Biopsy
2
relatlimab
1
prednylidene
1
palbociclib
1
olaparib
1
gallium 68 PSMA-11
1
deltacortene
1
abiraterone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urogenital Neoplasms
×
Radiotherapy
×
1 year
×
Clear all
No trials found.